🔴 Kailera Therapeutics is trading 4.04% down

Kailera Therapeutics is trading 4.04% down at $10.11, with no specific catalyst confirmed.

• No company announcement dated October 8 clearly explains the move; the latest corporate release located was dated October 1.
• A report linked the previous session’s decline to concern about the October 14 lock-up expiration, but did not establish it as the cause of this morning’s drop.
• Major indices were mixed to lower, without a broad market decline above 0.5%.